Japanese Guideline for Allergic Conjunctival Diseases
-
- Takamura Etsuko
- Department of Ophthalmology, Tokyo Women's Medical University, School of Medicine
-
- Uchio Eiichi
- Department of Ophthalmology, Fukuoka University, School of Medicine
-
- Ebihara Nobuyuki
- Department of Ophthalmology, Juntendo University School of Medicine
-
- Ohno Shigeaki
- Department of Ocular Inflammation and Immunology, Hokkaido University Graduate School of Medicine
-
- Ohashi Yuichi
- Department of Ophthalmology, Ehime University School of Medicine
-
- Okamoto Shigeki
- Okamoto Eye Clinic
-
- Kumagai Naoki
- Kumagai Eye Clinic
-
- Satake Yoshiyuki
- Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital
-
- Shoji Jun
- Division of Ophthalmology, Department of Visual Sciences, Nihon University, School of Medicine
-
- Nakagawa Yayoi
- Nakagawa Eye Clinic
-
- Namba Kenichi
- Department of Ophthalmology, Hokkaido University Graduate School of Medicine
-
- Fukagawa Kazumi
- Ryogoku Eye Clinic Department of Ophthalmology, Keio University School of Medicine
-
- Fukushima Atsuki
- Department of Ophthalmology, Kochi Medical School
-
- Fujishima Hiroshi
- Department of Ophthalmology, Tsurumi University Dental Hospital
Bibliographic Information
- Other Title
-
- Japanese guidelines for allergic conjunctival diseases 2017
Search this article
Abstract
The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease (Second Edition) revised in 2010. Allergic conjunctival disease is defined as "a conjunctival inflammatory disease associated with a Type I allergy accompanied by some subjective or objective symptoms." Allergic conjunctival disease is classified into allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis. Representative subjective symptoms include ocular itching, hyperemia, and lacrimation, whereas objective symptoms include conjunctival hyperemia, swelling, folliculosis, and papillae. Patients with vernal keratoconjunctivitis, which is characterized by conjunctival proliferative changes called giant papilla accompanied by varying extents of corneal lesion, such as corneal erosion and shield ulcer, complain of foreign body sensation, ocular pain, and photophobia. In the diagnosis of allergic conjunctival diseases, it is required that type I allergic diathesis is present, along with subjective and objective symptoms accompanying allergic inflammation. The diagnosis is ensured by proving a type I allergic reaction in the conjunctiva. Given that the first-line drug for the treatment of allergic conjunctival disease is an antiallergic eye drop, a steroid eye drop will be selected in accordance with the severity. In the treatment of vernal keratoconjunctivitis, an immunosuppressive eye drop will be concomitantly used with the abovementioned drugs.<br>
Journal
-
- Allergology International
-
Allergology International 60 (2), 191-203, 2011
Japanese Society of Allergology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679609912832
-
- NII Article ID
- 10031135567
- 130004477096
-
- NII Book ID
- AA11091750
-
- ISSN
- 14401592
- 13238930
-
- PubMed
- 21636966
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed